Curated News
By: NewsRamp Editorial Staff
April 15, 2025
GeoVax to Present at Emerging Growth Conference Following BARDA Contract Termination
TLDR
- GeoVax Labs, Inc. to discuss GEO-CM04S1 program and BARDA contract termination, providing valuable insights for investors.
- GeoVax Labs, Inc. will present at Emerging Growth Conference on April 16, 2025, focusing on GEO-CM04S1 program and BARDA contract termination details.
- GeoVax Labs, Inc.'s research on immunotherapies and vaccines aims to combat infectious diseases and improve cancer treatments, promising a brighter future for healthcare.
- Join the live online event to interact with GeoVax Labs, Inc.'s Chairman and CEO, David Dodd, and stay updated on groundbreaking developments in biotechnology.
Impact - Why it Matters
This news highlights GeoVax's strategic response to the termination of a key contract and offers stakeholders an opportunity to engage directly with the Company's leadership. Investors can gain valuable insights into GeoVax's pipeline of immunotherapies and vaccines, particularly the advanced COVID-19 vaccine program, potentially shaping investment decisions and future collaborations.
Summary
GeoVax Labs, Inc. will be presenting at the upcoming Emerging Growth Conference to discuss the recent termination of the GEO-CM04S1 contract from BARDA. The Company's Chairman and CEO, David Dodd, will provide insights and answer questions regarding this development.
GeoVax is a biotechnology company focused on developing immunotherapies and vaccines for cancers and infectious diseases. Their lead program, GEO-CM04S1, is a next-generation COVID-19 vaccine currently in Phase 2 clinical trials, targeting various patient populations. Additionally, the Company is advancing a gene-directed therapy for solid tumor cancers.
Investors and stakeholders are encouraged to participate in the conference to gain a better understanding of GeoVax's innovative programs and the impact of the recent contract termination on the Company's future direction.
Source Statement
This curated news summary relied on this press release disributed by NewMediaWire. Read the source press release here, GeoVax to Present at Emerging Growth Conference Following BARDA Contract Termination
